Bristol Myers Squibb plans another major round of job cuts in New Jersey, bringing the number of total layoffs the company ...
Par Health has issued a voluntary recall of two lots of the IV sedative dexmedetomidine HCl in 0.9% sodium chloride injection ...
As China and the U.S. presently duke it out over biopharma innovation supremacy, a clutch of Europe’s biggest drugmakers are calling on the bloc to not lose sight of its R&D roots. | As China and the ...
Eric Dube, Ph.D., the CEO who rebranded Travere Therapeutics and oversaw the launch of its rare kidney disease drug Filspari, will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results